Quarterly report [Sections 13 or 15(d)]

NOTES PAYABLE (Details Narrative)

v3.25.1
NOTES PAYABLE (Details Narrative) - USD ($)
 3 Months Ended
Aug. 01, 2024
Mar. 06, 2024
Jun. 01, 2023
Oct. 25, 2022
Jul. 28, 2020
Mar. 31, 2025
Mar. 31, 2024
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Interest Expense, Debt           $ 0 $ 800,000
Lenders [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt Instrument, Unamortized Discount       $ 3,000,000      
Loan Agreement [Member] | K2 HealthVentures LLC [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt conversion amount   $ 1,100,000 $ 900,000 5      
Debt conversion per share   $ 7.875 $ 4.5        
Warrants to purchase shares of common stock, exercised   142,857 194,444   2,873    
Warrant exercisable price per share         $ 208.8    
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche One [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Secured debt         $ 20,000,000    
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt conversion amount       $ 900,000      
Debt conversion per share       $ 4.5      
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt conversion amount       $ 1,100,000      
Debt conversion per share       $ 7.875      
Loan Agreement [Member] | Debt 2 [Member] | K2 HealthVentures LLC [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt conversion amount       $ 3,000,000      
Debt conversion per share       $ 282      
Amended loan agreement [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Loan Maturity Final Amount $ 11,800,000            
Debt Instrument Outstanding principal Amount 10,100,000            
Debt Instrument Periodic Payment Interest 1,600,000            
Final payment $ 1,600,000            
Amended loan agreement [Member] | K2 HealthVentures LLC [Member]              
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]              
Debt description         Interest payments were made monthly and accrued at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the "Prime Rate" plus 5.25%.